Here are six things to know:
1. Dr. Chang is the executive director of the University of California Irvine Health H.H. Chao Comprehensive Digestive Disease Center.
2. The EsophyX Z recently received FDA clearance.
3. Surgeons performtheTIF procedure, an incisionless procedure to treat gastroesophageal reflux disease’s symptoms, using the EsophyX device. The EsophyX Z is the device’s third generation.
4. Through the TIF procedure using the EsophyX Z device, physicians can reconstruct the gastroesophageal valve by performing a partial fundoplication.
5. Additionally, the the EsophyX Z device is compatible with the company’s existing 7.5 mm SerosaFuse Implantable Fastener cartridges.
6. The EsophyX Z device will enter a limited release in the United States before full commercialization during the summer of 2016.
More articles on GI/endoscopy:
Global capsule endoscopy market to grow at CAGR 14.8% until 2020: 5 trends
Expectant mothers taking IBD medication may impact their newborns — 5 points
SonarMD equipped with new features — 5 observations
